T he therapeutic potential of renal denervation (RDN) for cardiac arrhythmias was previously explored, yielding case reports and small case series that suggested RDN may be an effective adjunctive treatment in addition to medication and cardiac ablation for patients with ventricular tachycardia (VT) storm and atrial fibrillation.
RDN for Treating Ventricular Arrhythmias
as assessed by norepinephrine spillover, 8 its effects on cardiac sympathetic activity have not been studied in detail, especially beyond the acute phase of myocardial infarction (MI).
We, therefore, sought to determine the efficacy of RDN in preventing spontaneous VAs as monitored with an implantable cardioverter defibrillator (ICD) for ≤3 weeks after coronary occlusion and induced VAs in pigs. Concurrently, we explored RDN-induced modulation of sympathetic effectors on the myocardium. To test the hypothesis that RDN-induced reduction of myocardial sympathetic effectors leads to antiarrhythmic benefits in a postinfarct model, we performed percutaneous radiofrequency ablations along renal arteries to simulate RDN therapy in infarcted pigs. We quantified the neuronal damages inflicted in the renal arteries and analyzed spontaneous VAs continuously logged by ICDs, as well as induced arrhythmias brought on by programmed stimulation. We also assessed sympathetic nerve density in the infarcted hearts and tissue abundance of neuropeptide-Y (NPY) and nerve growth factor (NGF) in the myocardium. To confirm RDN-induced reduction of functional cardiac sympathetic effects, we also evaluated sinus tachycardia rates logged by the ICDs.
Methods
This randomized, controlled study was performed according to the guiding principles of the Canadian Council on Animal Care and conforms to the Guide for the Care and Use of Laboratory Animals, US National Institutes of Health (revised 2011). This protocol was approved by the Animal Care Committee of St Michael's Hospital. Randomization was performed at baseline before any of the experiments had been performed using a permuted block scheme generated by the website www.randomization.com.
Study Groups
The study was composed of 2 groups, totaling 14 pigs: 1. MI induction followed by sham RDN (n=8) 2. MI induction followed by real RDN (n=6)
Study Protocol
Each pig underwent 3 study sessions as part of this protocol:
Baseline Study
All pigs were evaluated with an echocardiogram and implanted with an ICD and were rested for at least 45 minutes before baseline measurements (arterial pressure recording, ECG, electrophysiological study) were taken. This was followed with MI by mid left anterior descending (LAD) coronary artery occlusion.
Midpoint Study (2 Weeks After Baseline Study)
After an echocardiogram, each pig had pre RDN measurements (arterial pressure recording, ECG, electrophysiological study) taken, followed by either a real or sham RDN, then rested for at least 30 minutes before post RDN acute measurements (same as pre RDN measurements except echocardiogram) were taken.
End Study (1 Week After Midpoint Study [3 Weeks After Baseline Study])
After an echocardiogram, end-study measurements of each pig (post RDN; arterial pressure recording, ECG, electrophysiological study) were taken. The pig was then euthanized for the harvesting of its heart and renal arteries.
A schematic illustration of the experimental protocol is shown in Figure 1 . See below and Methods in the Data Supplement for methodological details.
Study Animal Preparation
Healthy 10-to 12-week-old Yorkshire pigs of either sex (26-51 kg) were housed in the animal facility at the Li Ka Shing Knowledge Institute of St Michael's Hospital for at least 5 days before the baseline study. Pigs were fasted overnight and sedated with buprenorphine, ketamine, xylazine, and atropine (all intramuscular). Once anesthetized with isoflurane (≤5%), pigs were intubated for mechanical ventilation; anesthesia was maintained by continuous administration of isoflurane and oxygen. Because of limited access to chest leads in the pig model, 3 limb leads were placed for ECG recording. Two self-adhesive defibrillation pads placed on the left and right chest walls laterally were connected to an external biphasic defibrillator for emergency defibrillation.
Echocardiography
Echocardiography was performed as described in Methods in the Data Supplement.
ICD Implantation
Under sterile conditions, an incision was made in the lateral aspect of the neck over the left internal jugular vein, where a steroid-eluting, bipolar, IS-1 pacing/defibrillation lead (Durata; St Jude Medical, Minneapolis, MN) was inserted and then affixed to the right ventricular apex under fluoroscopic guidance. The lead was connected to a single-chamber ICD (Current or Fortify; St Jude Medical). Correct lead position was verified by fluoroscopy, as well as observing lead sensing (>5 mV) and lead impedance (500-1200 Ω). Each ICD was fixed in a cervical pocket and sutured in place. Programming consisted of a VF zone ≥270 bpm (20 intervals to detect) with antitachycardia pacing during charging, followed by 35 J shocks and a VT monitor zone ≥200 bpm (40 intervals to detect). These zones were the
WHAT IS KNOWN
• The pleotropic effects of renal sympathetic denervation range from a reduction in renal sympathetic output (reduced norepinephrine spillover) to attenuation of elevation in left ventricular end-diastolic pressure and reduced spontaneous ventricular fibrillation after acute myocardial infarction.
• Several trials without a sham control have suggested renal denervation has an antihypertensive effect; however, after the negative findings of the SYMPLICITY HTN-3 trial (Renal Denervation in Patients With Uncontrolled Hypertension), the clinical application for renal denervation is yet to be clearly defined.
WHAT THE STUDY ADDS
• This study shows that radiofrequency ablation within the renal artery damages nerve bundles and axons within and just beyond the adventitia of the artery.
• Renal denervation reduces sinus tachycardia rate and the incidence of spontaneous ventricular arrhythmias after myocardial infarction in a swine model.
• The changes in electrophysiology are seen concurrently with reduction of sympathetic nerves and tissue abundance of neuropeptide-Y in the infarct zone. RDN for Treating Ventricular Arrhythmias highest allowable with the longest detections allowable by the ICDs to minimize therapies for sinus tachycardia. Bradycardia therapy was programmed at VVI 50 bpm. Because of limited data storage on the ICDs, we elected not to log any other arrhythmias, such as nonsustained VTs with <40 beats. Premature ventricular complex counts could not be obtained from these single-chamber devices.
Arterial Pressure, ECG Recording, and Electrophysiology Study
Arterial pressure and ECG recordings and electrophysiological studies were performed as detailed in the Data Supplement.
Induction of Myocardial Infarction
Complete occlusion of the mid-LAD coronary artery was achieved by percutaneous angioplasty balloon inflation as detailed in the Data Supplement.
Renal Sympathetic Denervation
Through a femoral artery approach, the right and then the left renal arteries were identified and cannulated under fluoroscopic guidance. RDN was performed by delivering radiofrequency energy as described in the Data Supplement.
Neurofilament Score
Specimens were fixed in 10% neutral buffered formalin and processed in a blinded fashion to produce 4-mm-thick sections for immunohistochemical staining. The neurofilament antibody (clone alpha F11; Dako) was used at a 1/1200 dilution with the MACH4 kit. Stained sections were viewed and analyzed in Image Scope (Leica) at 20× magnification. For image annotation and scoring, first the outer demarcation of the adventitia was drawn. Measurements of 500 μm to the outside of this line were then taken, and the 500 μm outer perimeter from the end of the adventitia was drawn. The inner demarcation of the adventitia (ie, delineation of adventitia from media) was also drawn. Darkly stained neurofilament-positive structures were counted. Structures identifiable as blood vessels were excluded from the analysis. To be included as positive, at least 2 axonal structures must be identified. Neurofilament-positive structures appearing as one and the same (ie, having 2 cross-sections but associated with the same blood vessel) were scored as 1. Nerve bundles were scored as damaged if they showed markedly distended axons or the presence of macrophages. This analysis was conducted by a neuropathologist (Dr Kiehl) who was blinded to whether the animal had received RDN.
Spontaneous Arrhythmia Adjudication
All device recordings were individually adjudicated by an electrophysiologist who was blinded to the intervention given to each animal. The rhythm was adjudicated to be VA if it had an abrupt onset and offset and was associated with a morphology change on the farfield electrogram. Because of programming and memory capacity of ICD logs, only VAs of at least 20 intervals at ≥270 bpm (VF zone) or at least 40 intervals at ≥200 bpm (VT monitor zone) were recorded.
Sinus Tachycardia Documentation
Mean and peak sinus tachycardia rates were taken from ICD recordings as described in Methods in the Data Supplement.
Quantification of Cardiac Sympathetic Nerve
Presence of cardiac sympathetic nerve was analyzed as described in Methods in the Data Supplement.
Western Blot of NGF and NPY
Left ventricular tissues were analyzed for NGF and NPY by Western blotting as described in Methods in the Data Supplement. These analyses were conducted by a blinded technologist not aware of the treatments given to each animal.
Statistical Methods
The proportion of pigs with spontaneous VAs were compared categorically (any arrhythmias versus no arrhythmia) using McNemar's test. Episodes of spontaneous VAs and the occurrence of appropriate and inappropriate shocks were compared quantitatively using negative binomial mixed effects regression models to account for both time and RDN/sham RDN as variables. Episodes of induced VAs at electrophysiology study and the effects of RDN on NGF and NPY expression were compared using the Mann-Whitney test and mean, and peak sinus tachycardia rates were compared using repeated measures analysis of variance. The density of sympathetic nerves as observed in histological slides was compared using the Mann-Whitney test. Echocardiographic parameters, ERP, and the effect of RDN on blood pressure were compared using 2-way repeated measures analysis of variance. Healthy neurofilament scores were compared using the Mann-Whitney test, and the quantity of healthy and damaged nerves were compared using 2-way analysis of variance. Statistical analyses were performed with Stata, Version 13/14, and GraphPad Prism 5. A P value under 0.05 was considered significant.
Results
A total of 14 pigs were randomized for this study. Two pigs in the sham RDN group died after MI and sham RDN without completing the 3-week protocol. One of them was found dead in its cage 2 days before the end study, and the other died during induction of anesthesia before the end study could begin; both of them were excluded from analysis. There were no significant differences in baseline body weight, sex, and age between the 2 groups.
Verification of RDN and Renal Sympathetic Neuronal Damage
To validate the efficacy of the ablation, each renal artery was carefully examined; lesions were found in each of the arteries in the RDN group, but not in the sham RDN group. We stained specifically for neurofilament and quantified healthy Figure 2D through 2F). These data together suggest that the RDN procedure had indeed affected renal sympathetic nerves and document the reduction of healthy nerves in addition to the presence of disrupted nerves in the RDN group. There was also a nonsignificant decrease in the healthy neurofilament scores outside the adventitia. Figure 3 shows the incidence of spontaneous VAs recorded by ICDs during the 3-week protocol. In the real RDN group, 83% (5/6) of the pigs had spontaneous VAs in the period after MI, but none of these pigs (0/6) had spontaneous VAs after RDN (P=0.07, McNemar's test; Figure 3A ). In the sham RDN group, 50% (3/6) of the pigs had VAs after MI and prior to sham RDN treatment and during the ensuing week and 50% (3/6) of them had spontaneous VAs (P=0.61, McNemar's test; Figure 3A ). In the real RDN group, there were 14 spontaneous VAs in the 2 weeks post-MI (1.17 arrhythmias per pig/week) and 0 in the week after RDN (0 per pig/week). In the sham RDN group, there were 8 VAs in the 2 weeks post-MI (0.67 per pig/week) and 7 VAs in the 1 week after sham RDN (1.17 per pig/week). This represents a 100% reduction in the rate of spontaneous VAs per week in the real RDN group and a 75% increase in the rate of spontaneous VAs per week in the sham RDN group (P=0.03, negative binomial mixed effects regression model; Figure 3A through 3C) .
Spontaneous and Induced VAs
The difference in the incidence of appropriate (P=0.31) ICD shocks was not statistically significant in this study. Nor was there any difference in inappropriate shocks between the 2 groups (P=0.96; Figure 4A through 4C). With anesthesia induction, we found that pigs would often have a profound sinus tachycardia response, which lead to several inappropriate shocks for sinus tachycardia at the time of induction. Total number of inappropriate shocks was accounted for by just 6 different pigs, primarily at the time of anesthesia. After this was discovered, atropine was then removed from the induction protocol, and this largely mitigated inappropriate shocks at this time.
Inducible VAs at electrophysiological study were seen in 5/6 pigs in the sham RDN group post-MI and in 5/6 pigs after sham RDN. In the real RDN group, inducible VAs were seen in 3/6 pigs post-MI and in 3/6 pigs after real RDN (P=1.0 for interaction). 
Presence of Sympathetic Nerves in the Myocardium

Myocardial NPY and NGF Expression
Western blotting for NPY showed lower expression in the region of MI in the RDN group compared with that in the sham RDN (P=0.002) and also in noninfarcted tissue away from the lesion at the posterior myocardium (P=0.04; Figure 6A and 6B). In contrast, NGF expression was higher at the infarcted sites (P=0.03) and at sites away from the infarct lesion in the posterior myocardium (P=0.03) in RDN-treated pigs, when compared with that in corresponding tissues from sham-treated pigs ( Figure  6C and 6D) . A, An episode of rapid ventricular tachycardia (VT) that was successfully treated by a single shock from the pig implantable defibrillator. The mean cycle length of the VT was 185 ms (324 bpm), and the far-field signal (leadless ECG) shows a regular and broad complex rhythm consistent with ventricular tachycardia. B, Total number of appropriate shocks. There was no significant difference in the number of appropriate shocks after RDN (P=0.31, negative binomial mixed effects regression models). C, Total number of inappropriate shocks after RDN. There was no significant difference in the number of inappropriate shocks after RDN (P=0.96, negative binomial mixed effects regression models), n=6 in each group. EGM indicates electrogram; F, ventricular fibrillation interval sensed; HV, high voltage shock; and VP, ventricular pace. RDN for Treating Ventricular Arrhythmias
Mean and Peak Sinus Tachycardia Rates
The mean sinus tachycardia rates in the sham RDN group rose from 224±2 to 234±4 bpm, and in the real RDN group, they went from 225±7 to 219±5 bpm from pre RDN to post RDN, respectively (P=0.04 for the interaction). The peak sinus tachycardia rate for each pig was also significantly less in the real RDN group (261±7 to 276±13 bpm in the sham RDN group compared with 271±10 to 254±13 bpm in the real RDN group) from pre RDN to post RDN, respectively, P=0.03 for the interaction (Figure 7 ).
Discussion
In this randomized study, with blinded evaluation of end points, we tested the hypothesis that reduction of sympathetic activity induced by RDN would lead to antiarrhythmic benefits in a postinfarct pig model. We demonstrated that RDN reduces spontaneous VAs in this model ≤3 weeks after MI induction. Uniform loss of sympathetic nerves within and along renal arteries was confirmed in animals receiving RDN. This is an important aspect of this study given that in most instances, effective ablation of renal nerves was not confirmed with histology. We also demonstrated reduction in cardiac sympathetic activity on the basis of a reduction in the density of cardiac sympathetic nerves, reduction of myocardial NPY, and reduced peak and mean sinus tachycardia rates. These findings provide a mechanistic basis for alteration in myocardial substrate and triggers that maintain and give rise to VAs ≤3 weeks after MI.
Effect of RDN on Spontaneous and Induced VAs
Previous studies of the effects of RDN on VAs were limited to the early period of acute ischemia. Huang et al 7 reported
that incidences of PVCs and episodes of spontaneous VT/VF during LAD occlusion were reduced by RDN. Similarly, Linz et al 6 demonstrated that RDN decreased episodes of VF during LAD occlusion and the number of PVCs during the first 10 minutes of ischemia, but not the occurrence of VF during reperfusion. They also demonstrated that the reduction in PVCs and VF during ischemia after RDN was similar to the reduction caused by atenolol administration. 6 During the early stages of coronary occlusion, VAs occur predominantly because of reentry within the ischemic myocardium where depressed transmembrane potentials lead to slow conduction and block. 9 PVCs that initiate reentry may be reentrants themselves or may be because of triggered activity from Purkinje fibers in ischemic regions in response to increased catecholamine levels. 10 In the subacute period after acute MI, rapid VT may result from abnormal automaticity in surviving Purkinje fibers and possibly triggered activity. 9 These delayed arrhythmias may be promoted by increased cardiac sympathetic nerve activity 11 or by increased sensitivity of Purkinje fibers to catecholamines. 9 In the current study, where infarcts were relatively small (mean left ventricular ejection fraction at 55%) and sustained VAs were often difficult to induce at electrophysiological study or terminate with antitachycardia pacing, abnormal automaticity may have been a prominent mechanism. 9 By reducing cardiac sympathetic activity, RDN may be particularly effective in treating abnormal automaticity, providing one explanation as to why no pigs had further VAs after real RDN in this study. As beyond the subacute period after acute MI, spontaneous VAs are more likely to result from reentry involving slowly conducting surviving myocardial fibers, 9 and inducible arrhythmias are mostly related to scar formation; this could explain the discrepancy of the effects of RDN on spontaneous and inducible VAs in the current experimental model. Thus, the mechanism of benefit comes in the form of trigger reduction as opposed to substrate-based reduction of VAs. Through reducing sympathetic effectors, RDN may reduce the triggering of ectopic beats that initiate reentry at this stage or modify the electrophysiological properties of these reentry circuits.
Effect of RDN on Ventricular ERP
In a study by Huang et al 7 on RDN in animals with a normal healthy heart and in a study by Gu et al 12 of stellate ganglion blockade, sympathetic denervation resulted in prolonged ventricular ERP. In the current study, ventricular ERP in the real RDN group increased from 196±23 ms at baseline to 247±23 ms after RDN. This was a greater increase than what was reported by Huang et al 7 (≈15 ms on average); however, ERP was prolonged by a similar magnitude in the sham RDN and the RDN groups, suggesting that any possible ERP prolongation after RDN was masked by progressive fibrosis at the interface between the ICD lead and the myocardium in this study. Resterilized active ICD leads in this study would have lacked any remaining steroid at the tip and, hence, unlikely to prevent fibrosis.
Mean and Peak Sinus Tachycardia Rates
In the present study, the rise in mean sinus tachycardia rates (>200/minute as recorded by the ICDs) in infarcted hearts was attenuated by RDN. Moreover, the peak sinus tachycardia rates in these infarcted hearts increased in the sham RDN group and decreased in the real RDN group. Linz et al 13 demonstrated that RDN reduced the mean ventricular rates during atrial fibrillation by 24% and reduced heart rates during sinus rhythm by a mean of 20 bpm, consistent with the concept highlighted in our model. In the resistant hypertension setting, RDN reduced mean sinus rates more modestly by 2 to 3 bpm 14 and by 4 bpm 15 in 2 different studies. Reduction in mean and peak heart rates in association with reduced spontaneous VAs after RDN may both relate to lowered whole-body sympathetic activity mediated by a reduction in renal afferent nerve activity. 16 Conversely, faster heart beats may exacerbate the 
Presence of Cardiac Sympathetic Nerves and NPY
There was reduced staining for sympathetic nerves in infarcted hearts from the RDN group compared with that in the sham RDN group. Previous study suggested that acute MI results in nerve injury and subsequent sympathetic nerve sprouting with regional heterogeneous and hyper-innervated myocardium. 18 Patients with an increased density of sympathetic nerves after acute MI have an increased incidence of VAs, 18 and augmented sympathetic nerve sprouting by NGF infusion leads to a greater incidence of sudden cardiac death and VAs in dogs. 18 This sympathetic nerve sprouting hypothesis is also consistent with the evidence for β-blockade in preventing sudden cardiac death after MI. 19 Linz et al demonstrated that the reduction of atrial sympathetic nerve sprouting after RDN in goats is associated with decreased complexity of atrial fibrillation. 20 In our experimental model, reduction of sympathetic nerves in infarcted hearts after RDN treatment may be a key mechanism for reduced spontaneous VAs. Treatment with carvedilol after MI also ameliorated cardiac sympathetic nerve sprouting. 21 To explore the mechanism of the actions of RDN on cardiac sympathetic innervation, we assessed tissue abundance of NGF, a key regulator of nerve growth and maintenance in the myocardium. The presence of fewer sympathetic nerves in the myocardium despite a high level of NGF 3 weeks after MI induction suggests that RDN counteracts NGFmediated nerve growth in the infarcted heart. In infarcted heart failure models, NGF has been shown to be downregulated in response to sympathetic hyperactivity, 22 and this can lead to decreased sympathetic nerve density in the failing heart. Similarly, RDN may have mitigated the sympathetic hyperactivity seen after MI in our animal model and, therefore, attenuated the downregulation of NGF.
Injured nerves after interference of blood supply undergo Wallerian degeneration, which would be followed by axonal regeneration. 18, 23 Necrosis takes place early in the infarction, which may be followed by nerve regeneration 1 week later. 24 Our experimental protocol was not designed to study early changes, such as nerve necrosis; however, we studied myocardial nerves density 3 weeks after MI. The presence of fewer sympathetic nerves in the infarcted myocardium in our data supports the novel idea that RDN can prevent or suppress sympathetic hyperinnervation after infarction. This is an important finding as such adverse cardiac nerve development is known to be arrhythmogenic and is associated with sudden cardiac deaths. 18 This normalization of sympathetic hyperactivity is consistent with previous findings that RDN normalizes sympathetic nerve activity in hypertension. 16 Our study corroborates this paradigm in that a catheter-based single intervention can reduce the magnitude of cardiac sympathetic nerve activity in a postinfarct model. For VA management, β-blockers are the first-line drugs. 25 Though we did not study the effect of β-blocker in our experimental model, Linz et al 6 has shown that RDN is as effective as β-blockade in reducing PVCs and VF. The potential advantage of RDN as an alternative to β-blocker would be the lack of compliance concerns, generalized effects, and long-term costs.
Increased tissue NPY abundance was previously associated with increased sympathetic activity. 26, 27 Our Western blot analysis showed decreased levels of NPY at sites of MI and at sites distant from MI in the RDN group. The neurotransmitter NPY, a marker of sympathetic activity, has been demonstrated to be decreased after RDN. 28 Therefore, decreased NPY after RDN is consistent with the finding of reduced sympathetic nerve density and activity at the site of infarction and suggests that sympathetic nerve activity may also be reduced at noninfarcted sites as well. 
Effect of RDN on Renal Sympathetic Nerves
In the present study, the adventitia of renal arteries in the RDN group exhibited a significantly reduced healthy neurofilament score, with a nonsignificant decrease in the healthy neurofilament scores outside the adventitia (this study was likely underpowered to show a statistically significant difference in the healthy neurofilament scores outside the adventitia). As expected, damaged nerve bundles were only found in the RDN group, but not the sham RDN group, confirming that this was not because of instrument placement but RF treatment to the renal arteries. Seven days after RDN, axons are still in the process of degeneration. Degenerated axons and even the detached segment of axon have the ability to release neurotransmitters. 29, 30 Complete degeneration of the axon varies from animal to animal and species to species. [31] [32] [33] In our study, we euthanized the animals 7 days after RDN, and thus, our histological analysis was limited to such a time period. This time factor could explain why we observed variable neurofilament scores outside the adventitia where large renal sympathetic nerves can be found. These immunohistological findings also demonstrate the association of renal artery sympathetic denervation with the observed decreased spontaneous arrhythmias in our experimental model.
In conclusion, reduced spontaneous VAs after RDN may relate to reduced cardiac sympathetic activity after MI. These antiarrhythmic effects in the post-MI setting relate predominantly to trigger reduction as opposed to substrate alteration. The outcome measures in this study were objectively quantified, using device logs without room for subjective bias. This work provides new insight into sympathetic nerve reduction by RDN in the postinfarct myocardium, pointing to a novel aspect of the renal-cardiac axis for VAs reduction and calls for randomized trials to confirm this benefit in the clinical setting.
Limitations
To ensure the survival of pigs beyond initial MI, coronary occlusion was performed in such a way that the resultant lesions were relatively small, with a modest decrease in left ventricular ejection fraction. This is still of clinical relevance as a significant number of patients with MI are treated early with PCI and end up with no or only a modest reduction in EF. Another limitation of the study was the absence of comparison with β-blockade. In practice, RDN would be a single intervention after MI, as opposed to medical β-blockade with systemic effects and variable compliance. The present study assessed the role of RDN on VAs and reduction of cardiac sympathetic nerves that took place during the first 3 weeks post-MI; further studies are needed to determine whether these effects persist beyond this time period.
